The process of the RTK/RAS pathway driving prostate cancer lineage plasticity is a complex interplay involving multiple TFs, with TP63, FOXO1, and RORC potentially playing more crucial roles due to their relatively high activity levels. This evidence concerns the gene RORC and prostate carcinoma.